(S (NP (JJ Retinal) (NNS microaneurysms)) (VP (VBP are) (NP (NP (DT the) (JJS earliest) (JJ clinical) (NN sign)) (PP (IN of) (NP (JJ diabetic) (JJ retinopathy) (NN disease))))) (. .))
(S (NP (NP (NN Detection)) (PP (IN of) (NP (NN microaneurysms)))) (VP (VBZ is) (ADJP (ADJP (JJ crucial)) (PP (IN for) (NP (NP (NP (DT the) (JJ early) (NN diagnosis)) (PP (IN of) (NP (JJ diabetic) (NN retinopathy)))) (CC and) (NP (NP (NN prevention)) (PP (IN of) (NP (NN blindness)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (NP (DT a) (ADJP (NN novel) (CC and) (JJ reliable)) (NN method)) (PP (IN for) (NP (NP (JJ automatic) (NN detection)) (PP (IN of) (NP (NNS microaneurysms))) (PP (IN in) (NP (JJ retinal) (NNS images)))))) (VP (VBZ is) (VP (VBN proposed))) (. .))
(S (PP (IN In) (NP (NP (DT the) (JJ first) (NN stage)) (PP (IN of) (NP (DT the) (VBN proposed) (NN method))))) (, ,) (NP (JJ several) (JJ preliminary) (NN microaneurysm) (NNS candidates)) (VP (VBP are) (VP (VBN extracted) (S (VP (VBG using) (NP (NP (DT a) (NN gradient) (NN weighting) (NN technique)) (CC and) (NP (DT an) (JJ iterative) (NN thresholding) (NN approach))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ next) (NN stage))) (, ,) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NN intensity) (CC and) (NN shape) (NNS descriptors))))) (, ,) (NP (NP (DT a) (JJ new) (NN set)) (PP (IN of) (NP (NNS features))) (VP (VBN based) (PP (IN on) (NP (JJ local) (NN convergence) (NN index) (NNS filters))))) (VP (VBZ is) (VP (VBN extracted) (PP (IN for) (NP (DT each) (NN candidate))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (NP (DT the) (JJ collective) (NN set)) (PP (IN of) (NP (NNS features)))) (VP (VBZ is) (VP (VBN fed) (PP (TO to) (NP (DT a) (JJ hybrid) (VBG sampling/boosting) (NN classifier))) (S (VP (TO to) (VP (VB discriminate) (NP (DT the) (NNP MAs)) (PP (IN from) (NP (JJ non-MAs) (NNS candidates)))))))) (. .))
(S (NP (DT The) (NN method)) (VP (VBZ is) (VP (VBN evaluated) (PP (IN on) (NP (NP (NNS images)) (PP (IN with) (NP (NP (JJ different) (NNS resolutions) (CC and) (NNS modalities)) (PRN (-LRB- -LRB-) (NP (NNP RGB) (CC and) (NNP SLO)) (-RRB- -RRB-)))))) (S (VP (VBG using) (NP (NP (CD five) (ADJP (RB publicly) (JJ available)) (NNS datasets)) (PP (VBG including) (NP (NP (DT the) (NNP Retinopathy) (NNP Online) (NNP Challenge) (POS 's)) (NN dataset)))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN method)) (VP (VBZ achieves) (NP (NP (DT an) (JJ average) (NN sensitivity) (NN score)) (PP (IN of) (NP (CD 0.471))) (PP (IN on) (NP (DT the) (NNP ROC) (NN dataset)))) (S (VP (VBG outperforming) (NP (JJ state-of-the-art) (NNS approaches)) (PP (IN in) (NP (DT an) (JJ extensive) (NN comparison)))))) (. .))
(S (NP (NP (DT The) (JJ experimental) (NNS results)) (PP (IN on) (NP (DT the) (JJ other) (CD four) (NNS datasets)))) (VP (VBP demonstrate) (NP (NP (DT the) (NN effectiveness) (CC and) (NN robustness)) (PP (IN of) (NP (DT the) (VBN proposed) (NNS microaneurysms) (NN detection) (NN method))) (ADVP (NN regardless) (PP (IN of) (NP (JJ different) (NN image) (NNS resolutions) (CC and) (NNS modalities)))))) (. .))
